Keyphrases
Cystic Fibrosis
100%
Forced Expiratory Volume in 1 Second (FEV1)
27%
Inspiratory Capacity
17%
Omalizumab
16%
Allergic Bronchopulmonary Aspergillosis
16%
I1234V
16%
Israeli
16%
Risk Factors
15%
Cystic Fibrosis Transmembrane Conductance Regulator
13%
Lung Infection
12%
Lung Disease
12%
Asthma
11%
Lung
11%
Lung Function
11%
Tidal Volume
10%
Body Mass Index
10%
Airway Obstruction
9%
Expiratory Flow Limitation
9%
Tidal Flow
9%
Childrens
9%
Nutritional Status
9%
FEF25-75
8%
Allergy
8%
Ventilatory Limitation
8%
National Early Warning Score
8%
Resting Energy Expenditure
8%
Forced Vital Capacity
8%
Nocardia
8%
Gating mutation
8%
Ivacaftor
8%
Advanced Lung Disease
8%
Genetic Analysis
8%
Secondary Spontaneous Pneumothorax
8%
Diffusing Capacity
8%
Preconception Carrier Screening
8%
Capacity Deterioration
8%
Ataxia Telangiectasia
8%
Low Diffusion
8%
Familial Dysautonomia
8%
Modulator Therapy
8%
Prognostic Factors
8%
Multi-ethnic Society
8%
Pseudomonas Aeruginosa Biofilm
8%
Term Infants
8%
Non-surgical Treatment
8%
Respiratory Failure
8%
Clinical Score
8%
Molecular Characteristics
8%
COVID-19
8%
Diaphragmatic Paralysis
8%
Medicine and Dentistry
Cystic Fibrosis
57%
Patient with Cystic Fibrosis
28%
Deterioration
19%
Inspiratory Capacity
17%
Silo-Filler's Disease
15%
Breathing
14%
Airway Obstruction
13%
Expiratory Flow
10%
Tidal Volume
10%
Conservative Treatment
9%
Spirometry
9%
Nutritional Status
9%
COVID-19
8%
Spontaneous Pneumothorax
8%
Plication
8%
Genetic Analysis
8%
Diaphragm Paralysis
8%
Resting Energy Expenditure
8%
Respiratory Failure
8%
Nocardia
8%
Forced Vital Capacity
8%
Advanced Lung Disease
8%
Dysautonomia
8%
Ataxia Telangiectasia
8%
Lifespan
8%
Lung Diffusion Capacity
8%
Prognostic Factor
8%
Toddlers
8%
Injury
8%
Lung Infection
8%
Prematurity
8%
Mycobacterium abscessus
8%
Treatment Duration
8%
Nitric Oxide
8%
Lung Function Test
8%
Lung Volume
7%
Triage
6%
Forced Expiratory Volume
6%
Body Mass Index
6%
Lung Transplantation
5%
